BridgeBio Pharma (BBIO) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to -$7.3 million.
- BridgeBio Pharma's Other Gross PP&E Adjustments rose 2908.68% to -$7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.3 million, marking a year-over-year increase of 2908.68%. This contributed to the annual value of -$9.4 million for FY2024, which is 6785.51% up from last year.
- Per BridgeBio Pharma's latest filing, its Other Gross PP&E Adjustments stood at -$7.3 million for Q3 2025, which was up 2908.68% from -$13.3 million recorded in Q2 2025.
- BridgeBio Pharma's 5-year Other Gross PP&E Adjustments high stood at -$7.3 million for Q3 2025, and its period low was -$29.5 million during Q1 2024.
- Over the past 5 years, BridgeBio Pharma's median Other Gross PP&E Adjustments value was -$16.0 million (recorded in 2022), while the average stood at -$17.4 million.
- Per our database at Business Quant, BridgeBio Pharma's Other Gross PP&E Adjustments tumbled by 10249.54% in 2024 and then skyrocketed by 6888.35% in 2025.
- Over the past 5 years, BridgeBio Pharma's Other Gross PP&E Adjustments (Quarter) stood at -$26.1 million in 2021, then decreased by 2.57% to -$26.8 million in 2022, then decreased by 9.53% to -$29.4 million in 2023, then soared by 67.86% to -$9.4 million in 2024, then grew by 23.17% to -$7.3 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$7.3 million for Q3 2025, versus -$13.3 million for Q2 2025 and -$9.2 million for Q1 2025.